Details of the Drug

General Information of Drug (ID: DM9EWN8)

Drug Name

1-Hydroxy-2-Amino-3-Cyclohexylpropane

Synonyms

(S)-2-Amino-3-cyclohexylpropan-1-ol; 131288-67-0; (S)-2-Amino-3-cyclohexyl-propan-1-ol; 1-Hydroxy-2-Amino-3-Cyclohexylpropane; CHEMBL1231778; (S)-2-AMINO-3-CYCLOHEXYL-1-PROPANOL; (2S)-2-Amino-3-Cyclohexylpropan-1-Ol Hydrochloride; 205445-49-4; (2S)-2-amino-3-cyclohexylpropan-1-ol; AC1L9GJG; AC1Q4UB7; SCHEMBL82667; S-2-Amino-3-cyclohexylpropanol; KS-00000LNV; QWDRYURVUDZKSG-VIFPVBQESA-N; MolPort-000-000-987; ZINC154757; ZX-CM013052; (S)-cyclohexylalaninol, AldrichCPR; BDBM50367060; FCH835925; AKOS022180681; MB00862; DB04387

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

157.25

Topological Polar Surface Area (xlogp)

1.9

Rotatable Bond Count (rotbonds)

3

Hydrogen Bond Donor Count (hbonddonor)

2

Hydrogen Bond Acceptor Count (hbondacc)

2

Chemical Identifiers

Formula: C9H19NO
IUPAC Name: (2S)-2-amino-3-cyclohexylpropan-1-ol
Canonical SMILES: C1CCC(CC1)C[C@@H](CO)N
InChI: InChI=1S/C9H19NO/c10-9(7-11)6-8-4-2-1-3-5-8/h8-9,11H,1-7,10H2/t9-/m0/s1
InChIKey: QWDRYURVUDZKSG-VIFPVBQESA-N

Cross-matching ID

PubChem CID: 444569
CAS Number: 205445-49-4
DrugBank ID: DB04387
TTD ID: D06OBP

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Angiotensinogenase renin (REN)	TTB2MXP	RENI_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2	Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patie... J Renin Angiotensin Aldosterone Syst. 2009 Sep;10(3):157-67.
3	Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol. 2006 Mar;290(3):F710-9.
4	Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes. Exp Eye Res. 2012 Jan;94(1):146-9.
5	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033655)
6	Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca. J Hypertens Suppl. 1989 Apr;7(2):S33-5.
7	Synergistic effect on reduction in blood pressure with coadministration of the renin inhibitor, CP-80,794, and the angiotensin converting enzyme inhibitor, captopril. J Cardiovasc Pharmacol. 1992 Jul;20(1):75-82.
8	New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon . Curr Hypertens Rep. 2015; 17(6): 42.
9	Drug-drug interaction study of ACT-178882, a new renin inhibitor, and diltiazem in healthy subjects. Clin Drug Investig. 2013 Mar;33(3):207-13.
10	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2413).
11	Antihypertensive efficacy of FK906, a novel human renin inhibitor. Clin Ther. 1993 May-Jun;15(3):539-48.